......

Myocarditis Risk in Young Men Is Not Rare

U.S. Vaccine Adverse Events Reporting System (VAERS) data also raise questions about the risk of potentially lethal myocarditis, especially in boys. The following slide was presented during a June 23, 2021, meeting convened by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP), to discuss the risk of myopericarditis.

As you can see, the observed rates of myocarditis and/or pericarditis for several age groups, and especially among males, are significantly higher than the expected background rate.

This is a loud and clear safety signal, yet the ACIP proceeded to recommend the shot to preteens and teens anyway, and in a public statement insisted that myopericarditis is “an extremely rare side effect” that “only an exceedingly small number of people will experience after vaccination.” How can they say that with data like this right in front of their noses?

.......

Specific goals: Examine the prevalence of side-effects in temporal proximity to the third shot grouped according to age and gender. Examine the time of onset relative to administration of the vaccine and the duration thereof, and to compare it with the side-effects of previous vaccines.”

In all, 2,894 people were contacted and 2,068 agreed to be interviewed (response rate: 71.4%). Of those 2,068 boosted individuals:

• 0.3% required hospitalization for an adverse event
• 4.5% experienced one or more neurological problems (2.1% of men and 6.9% of women), such as tingling or itching sensation, Bell’s palsy, vision damage, memory deterioration, hearing damage, convulsions, loss of consciousness and more
• 9.6% of women under the age of 54 experienced menstrual irregularities. Of those, “39% suffered from similar side-effects after prior COVID-19 vaccinations; however most (67%) indicated that the side-effects waned prior to the third vaccination and returned after receiving it”
• 26.4% of those with preexisting anxiety disorder or depression experienced a worsening of their symptoms
• 24.2% of those with preexisting autoimmune disorders experienced exacerbation of disease

Between 6.3% and 9.3% of those with preexisting high blood pressure, lung disease, diabetes and heart disease also reported that their condition was exacerbated after the third booster. A small number of women, but no men, also reported herpes infections (0.4% for herpes simplex infections and 0.3% for herpes zoster). Other key take-home’s from this Israeli report are that:

• Side-effects are more common among women and younger people
• 1 in 10 women suffer menstrual irregularities
• Neurological side effects typically don’t appear until about a month after the jab
• In the majority of cases, the occurrence of a given side effect was not more severe after the third shot compared to the two previous doses. Put another way, the severity of side effects tends to be the same, regardless of the number of doses, so these finding can perhaps be applied to doses 1 and 2 as well